Top Markets
#1 MowCat MowCat +48.89%
#2 Bermuda Shorts Bermuda Shorts +30.33%
#3 Velvet Velvet +26.11%
#4 aPriori aPriori +22.89%
#5 Derive Derive +19.95%
#6 Biconomy Biconomy +19.15%
#7 Audiera Audiera +18.63%
#8 Quack AI Quack AI +16.83%
#9 Perle Perle +13.71%
#10 Block Street Block Street +10.44%
Coin of the day
MowCat MowCat
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
CollPlant Biotechnologies Ltd. CollPlant Biotechnologies Ltd.

CollPlant Biotechnologies Ltd.

CLGN
Classement en actions #35204
CollPlant Biotechnologies Ltd. is a regenerative and aesthetic medicine... CollPlant Biotechnologies Ltd. is a regenerative and aesthetic medicine enterprise operating across the United States, Canada, and Europe. The company primarily engages in the three-dimensional (3D) bioprinting of tissues and organs, alongside developing solutions for medical aesthetics. All of CollPlant's offerings are underpinned by its proprietary plant-based genetic engineering technology, which facilitates the production of recombinant type I human collagen. Its diverse product portfolio encompasses BioInks engineered for 3D tissue and organ fabrication; dermal and soft tissue fillers designed to diminish wrinkles; and innovative breast implants, both 3D bioprinted and injectable, aimed at promoting breast tissue regeneration. CollPlant also provides a 3D bioprinted regenerative soft tissue matrix. Specialized products include VergenixSTR, a soft tissue repair matrix targeting tendinopathy, and VergenixFG, an advanced wound care treatment for deep surgical incisions and persistent wounds such as diabetic, venous, and pressure ulcers, burns, and bedsores. The company maintains strategic collaboration agreements with numerous partners, including 3D Systems Corporation, CellInk (a BICO Group company), the Advanced Regenerative Manufacturing Institute, the RegenMed Development Organization, Israel's Technion Institute of Technology, AbbVie, and STEMCELL. Established in Rehovot, Israel, in 2004, the company was formerly known as CollPlant Holdings Ltd. before adopting its current name in June 2019.
Prix de l'action
$0.3299
Dernière synchronisation: 2026-08-14
Capitalisation boursière
$4.28M
Changement (1 jour)
3.55%
Changement (1 an)
-87.06%
Pays
IL
Échange CollPlant Biotechnologies Ltd. (CLGN)

Catégorie

Healthcare
Historique du prix de l'action pour CollPlant Biotechnologies Ltd. (CLGN)
Prix de clôture le plus élevé : $0.32 le 2026-08-01

Prix de clôture le plus bas : $8.98 le 2018-01-01
Historique du prix de l'action de CollPlant Biotechnologies Ltd. de 2018 à 2026
Performance annuelle du prix de l'action
Année Performance
2026 (TTM) -26.63%
2025 -54.90%
2024 -30.62%
2023 -34.12%
2022 -45.82%
2021 60.55%
2020 77.36%
2019 17.77%
2018 0.00%
Prix de l'action pour des entreprises similaires ou concurrentes
Entreprise Prix de l'action Variation 1a% Pays
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $505.24 28.63%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $846.09 29.41%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $731.69 6.47%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.07K -6.40%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $251.82 11.75%
BE